OrderlyMeds Tirzepatide Review

What OrderlyMeds charges for tirzepatide, what is bundled, and what it publishes before you pay.

Released: · Last reviewed:

Researched By Dr. Parmis · Medical Researcher · Western University of Health Sciences

Medically Reviewed By Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: · This page is informational and does not constitute medical advice.

Direct answer

As of October 15, 2026, OrderlyMeds charges $299 a month all-in for compounded tirzepatide at a 10 mg dose, month to month, the same at every dose. That is $3,588 over twelve months at that dose, based on its own pricing page.

All-in means medication plus any mandatory recurring fee, month to month, before prepaid discounts and tax.

Price basis

All-in monthly cost = medication plus any mandatory recurring fee, at a named dose, month to month, before tax and before prepaid discounts. Competitor prices read October 15, 2026; NexLife’s as of November 6, 2026. How we verify a price.

OrderlyMeds tirzepatide price by dose

OrderlyMeds all-in tirzepatide price at each dose, month to month. Read Oct 15, 2026, changed since August. A dash means no price is printed for that dose.
DoseAll-inTwelve months at this dose
2.5 mg$299$3,588
5 mg$299$3,588
7.5 mg$299$3,588
10 mg$299$3,588
12.5 mg$299$3,588
15 mg$299$3,588

Fees, billing and terms at OrderlyMeds

What OrderlyMeds publishes about fees and terms. “Not published” means we could not find it on its own pages.
ItemOrderlyMeds
Pricing modelsame price at every dose
Membership or program feenone
Billingmonthly
Multi-month or prepaid option2-month starter for new customers, $299 in total
Pharmacy“our pharmacy” (not named)
Productcompounded tirzepatide (not FDA-approved)
Price statusread Oct 15, 2026, changed since August
Page we readorderlymeds.com

What OrderlyMeds’s own pages say

$299 a month at any dose with no membership. New customers can take a two-month starter for $299 in total.

Recorded wording: “Monthly plans Compounded Tirzepatide GLP-1 injections $299; "Does the price increase with the dose? No!"”

Pros and cons

What works

  • One price at every dose, so moving up the dose ladder does not change the bill.
  • No separate membership or program fee on the pages we read.
  • Multi-month option published: 2-month starter for new customers, $299 in total.

What to check

  • Does not name the dispensing pharmacy on the pages we read.
  • Compounded tirzepatide is not FDA-approved; it is made with the drug in Zepbound but is not the same product.

Where OrderlyMeds sits among the programs we compare

Of the 15 programs with a month-to-month tirzepatide price we can place at 10 mg, 7 are lower than OrderlyMeds and 2 charge the same (ShedRx, SkinnyRx). The group runs $129 to $399, median $299. This is a price position, not a quality ranking.

See the all-in cost table for every row and the methodology for how prices are read.

Head-to-head pages with OrderlyMeds

Questions about OrderlyMeds

How much does OrderlyMeds charge for tirzepatide?

As of October 15, 2026, OrderlyMeds charges $299 a month all-in for compounded tirzepatide at a 10 mg dose, month to month, the same at every dose. That is $3,588 over twelve months at that dose, based on its own pricing page.

How does OrderlyMeds compare with NexLife on price?

At a 10 mg dose month to month, OrderlyMeds is $299/mo against NexLife’s $129 a month, which is $2,040 a year more than NexLife (prices read October 15 and November 6, 2026). NexLife’s 12-month plan is $115 a month.

Does OrderlyMeds name its pharmacy?

Not by name on the pages we read. What we recorded: “our pharmacy” (not named). A named pharmacy can be checked on its state board of pharmacy register.

Is compounded tirzepatide FDA-approved?

No. Compounded tirzepatide is made with the drug in Zepbound but is not the same product, and FDA does not review compounded drugs for safety, effectiveness or quality before they are sold. Zepbound and Mounjaro are the FDA-approved tirzepatide products.

How current is this page?

Prices on this page were read on the program’s own site on October 15, 2026. We re-read programs on a schedule and log changes on the corrections page.

Sources